These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1011472)

  • 21. The prevention of postoperative deep vein thrombosis and pulmonary embolism with low dose subcutaneous heparin and dextran.
    Verstraete M
    Surg Gynecol Obstet; 1976 Dec; 143(6):981-5. PubMed ID: 996722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Complex treatment of acute venous thrombosis with the use of reginal perfusion and infusion of anticoagulants and thrombolytic agents].
    Alekseev PP; Larionov VG
    Sov Med; 1969; 32(7):17-21. PubMed ID: 4245510
    [No Abstract]   [Full Text] [Related]  

  • 23. Occurrence of soluble very high molecular weight fibrinogen complexes in hypercoagulable states. An in vitro and in vivo study on their features.
    Neri Serneri GG; Gensini GF; Abbate R; Favilla S
    Thromb Haemost; 1980 Feb; 42(5):1561-73. PubMed ID: 6768154
    [No Abstract]   [Full Text] [Related]  

  • 24. [Experimental studies on continuous local infusion of anticoagulants for reconstruction of small arteries].
    Sasamoto Y
    Kumamoto Igakkai Zasshi; 1970 Sep; 44(9):839-52. PubMed ID: 5537140
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevention of venous thrombosis after total hip arthroplasty. Antithrombin III and low-dose heparin compared with dextran 40.
    Francis CW; Pellegrini VD; Marder VJ; Harris CM; Totterman S; Gabriel KR; Baughman DJ; Roemer S; Burke J; Goodman TL
    J Bone Joint Surg Am; 1989 Mar; 71(3):327-35. PubMed ID: 2466846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving use of heparin in acute deep venous thrombosis.
    Gold JA; Ferguson CJ; Williams NF; Braun SK
    Wis Med J; 1996 May; 95(5):311-2. PubMed ID: 8936037
    [No Abstract]   [Full Text] [Related]  

  • 27. [Intra-arterial infusions in the treatment of obliterating diseases of the arteries of the lower limbs].
    Parakhoniak VI; Ovchinnikov VA; Mizinov KN
    Khirurgiia (Mosk); 1976 Nov; (11):104-8. PubMed ID: 1011564
    [No Abstract]   [Full Text] [Related]  

  • 28. Changes in blood coagulation during infusion of intralipid.
    Reid DJ; Ingram GI
    Clin Sci; 1967 Oct; 33(2):399-407. PubMed ID: 6058437
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of acute thrombophlebitis of the lower limbs with long-term intraosseous drug infusions].
    Mel'nik VM
    Vestn Khir Im I I Grek; 1979 Nov; 123(11):64-6. PubMed ID: 524666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of unfragmented heparin alone and in combination with dextran on experimental venous thrombosis in rabbits.
    Matthiasson SE; Lindblad B; Mätzsch T; Bergqvist D
    Thromb Res; 1993 Oct; 72(2):169-72. PubMed ID: 7508152
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of dextran 40,000 on the dynamics of blood clotting in thromboelastographic studies].
    Sulek K
    Pol Tyg Lek; 1971 Apr; 26(14):497-9. PubMed ID: 5574220
    [No Abstract]   [Full Text] [Related]  

  • 32. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis.
    Hull RD; Raskob GE; Hirsh J; Jay RM; Leclerc JR; Geerts WH; Rosenbloom D; Sackett DL; Anderson C; Harrison L
    N Engl J Med; 1986 Oct; 315(18):1109-14. PubMed ID: 3531862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hemorheology and blood thrombotic potential in pulmonary thromboembolism].
    Aleksandrova NP; Virganskiĭ AO; Leont'ev SG; Berezov VP
    Grud Serdechnososudistaia Khir; 1990; (9):43-7. PubMed ID: 2261255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. beta-thromboglobulin and heparin-neutralising activity test in clinical conditions.
    Lancet; 1977 May; 1(8022):1153-4. PubMed ID: 68249
    [No Abstract]   [Full Text] [Related]  

  • 35. [Signs of thrombin formation in venous occlusion in patients with ischemic heart disease and the role of the protein C activation system in its utilization].
    Panchenko EP; Averkov OV; Dobrovol'skiĭ AB; Zateĭshchikov DA; Storozhilova AN; Ignashenkova GV; Gratsianskiĭ NA
    Kardiologiia; 1991 Mar; 31(3):10-3. PubMed ID: 1908538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laboratory control of continuous intravenous heparin therapy with Howel time and activated partial thromboplastin time. A prospective, randomized and blind study.
    Almazan A; Lozano F; Ramos M; Rodriguez-Moran M; Gomez-Alonso A
    Angiology; 1985 Jun; 36(6):363-9. PubMed ID: 4025944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of a new polyfunctional plasma substitute rheogluman in complex infusion therapy of acute pancreatitis].
    Terekhov NT; Bychkov VV
    Klin Khir (1962); 1980 Mar; (3):4-7. PubMed ID: 6154825
    [No Abstract]   [Full Text] [Related]  

  • 38. Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis.
    Hull R; Delmore T; Genton E; Hirsh J; Gent M; Sackett D; McLoughlin D; Armstrong P
    N Engl J Med; 1979 Oct; 301(16):855-8. PubMed ID: 384248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The present status of acute deep venous thrombosis.
    Strandness DE; Ward K; Krugmire R
    Surg Gynecol Obstet; 1977 Sep; 145(3):433-45. PubMed ID: 888067
    [No Abstract]   [Full Text] [Related]  

  • 40. The value of monitoring heparin therapy in the prevention of recurrence in patients with venous thromboembolic disease.
    Hirsh J
    Thromb Diath Haemorrh Suppl; 1973; 56():181-90. PubMed ID: 4805494
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.